Anastrozole gives long lasting protection against breast cancer
BBC - 12-Dec-2019High-risk, post-menopausal women should ask their doctor about Anastrozole
Join the club for FREE to access the whole archive and other member benefits.
Professor and research scientist with an interest in cancer prevention
Based at Queen Mary University of London , Professor Cuzick works in cancer prevention. He and his team are particularly interested in breast, prostate, cervical and bowel cancers.One area of Professor Cuzick’s research is looking for ‘biological signposts’ that could help predict people’s risk of developing different types of cancer. Predicting risk more precisely could lead to more tailored screening and identify people who may benefit from treatments that reduce their risk. Professor Cuzick is also leading ground-breaking clinical trials to test treatments that might reduce the risk of developing certain types of cancer. For example, his research has already shown that giving women at high risk of breast cancer hormone therapies dramatically reduced their risk.
See also: Queen Mary University of London - Public research university in London, England
Details last updated 13-Dec-2019
High-risk, post-menopausal women should ask their doctor about Anastrozole